Selected research
Industry Research
Ophthalmic Medicine Industry Research Report 2026
Market perspective
The global Ophthalmic Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ophthalmic Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ophthalmic Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ophthalmic Medicine include Zhejiang Shapuaisi Pharmaceutical, Shenyang Xingqi Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Novaliq, Mentholatum, Bausch Health and Alcon NV, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ophthalmic Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ophthalmic Medicine Market by Company
Zhejiang Shapuaisi Pharmaceutical
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Novaliq
Mentholatum
Bausch Health
Alcon NV
Ophthalmic Medicine Segment by Type
Eye Drops
Gelling Agent
Tablet
Eye Ointment
Injection
Ophthalmic Medicine Segment by Application
Cataract
Anti-infective
Anti-fatigue and Dryness
Ophthalmic Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ophthalmic Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ophthalmic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Eye Drops
- Gelling Agent
- Tablet
- Eye Ointment
- Injection
Applications
- Cataract
- Anti-infective
- Anti-fatigue and Dryness
Companies covered
- Zhejiang Shapuaisi Pharmaceutical
- Shenyang Xingqi Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- Santen Pharmaceutica
- Novaliq
- Mentholatum
- Bausch Health
- Alcon NV
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ophthalmic Medicine Market Size (2021-2032)
- 2.2.2 Global Ophthalmic Medicine Sales (2021-2032)
- 2.2.3 Global Ophthalmic Medicine Market Average Price (2021-2032)
- 2.3 Ophthalmic Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Eye Drops
- 2.3.3 Gelling Agent
- 2.3.4 Tablet
- 2.3.5 Eye Ointment
- 2.3.6 Injection
- 2.4 Ophthalmic Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cataract
- 2.4.3 Anti-infective
- 2.4.4 Anti-fatigue and Dryness
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ophthalmic Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ophthalmic Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ophthalmic Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Ophthalmic Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Ophthalmic Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ophthalmic Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ophthalmic Medicine, Product Type & Application
- 3.8 Global Manufacturers of Ophthalmic Medicine, Established Date
- 3.9 Global Ophthalmic Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Shapuaisi Pharmaceutical
- 4.1.1 Zhejiang Shapuaisi Pharmaceutical Company Information
- 4.1.2 Zhejiang Shapuaisi Pharmaceutical Business Overview
- 4.1.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
- 4.1.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments
- 4.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
- 4.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
- 4.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview
- 4.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
- 4.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments
- 4.3 Chengdu Kanghong Pharmaceutical Group
- 4.3.1 Chengdu Kanghong Pharmaceutical Group Company Information
- 4.3.2 Chengdu Kanghong Pharmaceutical Group Business Overview
- 4.3.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
- 4.3.5 Chengdu Kanghong Pharmaceutical Group Recent Developments
- 4.4 Santen Pharmaceutica
- 4.4.1 Santen Pharmaceutica Company Information
- 4.4.2 Santen Pharmaceutica Business Overview
- 4.4.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
- 4.4.5 Santen Pharmaceutica Recent Developments
- 4.5 Novaliq
- 4.5.1 Novaliq Company Information
- 4.5.2 Novaliq Business Overview
- 4.5.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novaliq Ophthalmic Medicine Product Portfolio
- 4.5.5 Novaliq Recent Developments
- 4.6 Mentholatum
- 4.6.1 Mentholatum Company Information
- 4.6.2 Mentholatum Business Overview
- 4.6.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mentholatum Ophthalmic Medicine Product Portfolio
- 4.6.5 Mentholatum Recent Developments
- 4.7 Bausch Health
- 4.7.1 Bausch Health Company Information
- 4.7.2 Bausch Health Business Overview
- 4.7.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bausch Health Ophthalmic Medicine Product Portfolio
- 4.7.5 Bausch Health Recent Developments
- 4.8 Alcon NV
- 4.8.1 Alcon NV Company Information
- 4.8.2 Alcon NV Business Overview
- 4.8.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Alcon NV Ophthalmic Medicine Product Portfolio
- 4.8.5 Alcon NV Recent Developments
5 Global Ophthalmic Medicine Market Scenario by Region
- 5.1 Global Ophthalmic Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ophthalmic Medicine Sales by Region: 2021-2032
- 5.2.1 Global Ophthalmic Medicine Sales by Region: 2021-2026
- 5.2.2 Global Ophthalmic Medicine Sales by Region: 2027-2032
- 5.3 Global Ophthalmic Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Ophthalmic Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Ophthalmic Medicine Revenue by Region: 2027-2032
- 5.4 North America Ophthalmic Medicine Market Facts & Figures by Country
- 5.4.1 North America Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ophthalmic Medicine Sales by Country (2021-2032)
- 5.4.3 North America Ophthalmic Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ophthalmic Medicine Market Facts & Figures by Country
- 5.5.1 Europe Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ophthalmic Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Ophthalmic Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ophthalmic Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ophthalmic Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ophthalmic Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ophthalmic Medicine Market Facts & Figures by Country
- 5.7.1 South America Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ophthalmic Medicine Sales by Country (2021-2032)
- 5.7.3 South America Ophthalmic Medicine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Ophthalmic Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ophthalmic Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ophthalmic Medicine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ophthalmic Medicine Sales by Type (2021-2032)
- 6.1.1 Global Ophthalmic Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Ophthalmic Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Ophthalmic Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Ophthalmic Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ophthalmic Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Ophthalmic Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ophthalmic Medicine Sales by Application (2021-2032)
- 7.1.1 Global Ophthalmic Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ophthalmic Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Ophthalmic Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Ophthalmic Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ophthalmic Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Ophthalmic Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ophthalmic Medicine Value Chain Analysis
- 8.1.1 Ophthalmic Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ophthalmic Medicine Production Mode & Process
- 8.2 Ophthalmic Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ophthalmic Medicine Distributors
- 8.2.3 Ophthalmic Medicine Customers
9 Global Ophthalmic Medicine Analyzing Market Dynamics
- 9.1 Ophthalmic Medicine Industry Trends
- 9.2 Ophthalmic Medicine Industry Drivers
- 9.3 Ophthalmic Medicine Industry Opportunities and Challenges
- 9.4 Ophthalmic Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst